Selected research
Industry Growth & Trends
Global Life Sciences Transactions Service Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Life Sciences Transactions Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Life Sciences Transactions Service is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Life Sciences Transactions Service is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Life Sciences Transactions Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Life Sciences Transactions Service market include A&L Goodbody, Arnold & Porter, Baker McKenzie, Covington, DLA Piper, HaysMac, Holland & Knight, Kirkland & Ellis LLP and L.E.K. Consulting, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Life Sciences Transactions Service market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Life Sciences Transactions Service market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Life Sciences Transactions Service market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Life Sciences Transactions Service.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Life Sciences Transactions Service market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Life Sciences Transactions Service Market by Company
A&L Goodbody
Arnold & Porter
Baker McKenzie
Covington
DLA Piper
HaysMac
Holland & Knight
Kirkland & Ellis LLP
L.E.K. Consulting
Morgan Lewis
Osborne Clarke
Pharma Bio Source
Pinnacle
Reed Smith LLP
RNA Advisors
Sidley Austin
Tenthpin
Troutman Pepper Locke
WilmerHale
Life Sciences Transactions Service Segment by Type
Intellectual Property Licensing Transactions
Product Asset Transactions
Equity Mergers and Acquisitions
Other
Life Sciences Transactions Service Segment by Application
Biopharmaceuticals and Innovative Therapies
Medical Devices and Diagnostics
Contract Research, Development, and Manufacturing Organizations
Digital Health and Healthcare Services
Others
Life Sciences Transactions Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Life Sciences Transactions Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Life Sciences Transactions Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Life Sciences Transactions Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Life Sciences Transactions Service companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Intellectual Property Licensing Transactions
- Product Asset Transactions
- Equity Mergers and Acquisitions
- Other
Applications
- Biopharmaceuticals and Innovative Therapies
- Medical Devices and Diagnostics
- Contract Research, Development, and Manufacturing Organizations
- Digital Health and Healthcare Services
- Others
Companies covered
- A&L Goodbody
- Arnold & Porter
- Baker McKenzie
- Covington
- DLA Piper
- HaysMac
- Holland & Knight
- Kirkland & Ellis LLP
- L.E.K. Consulting
- Morgan Lewis
- Osborne Clarke
- Pharma Bio Source
- Pinnacle
- Reed Smith LLP
- RNA Advisors
- Sidley Austin
- Tenthpin
- Troutman Pepper Locke
- WilmerHale
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Life Sciences Transactions Service Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Life Sciences Transactions Service Market Size by Region (2021-2032)
- 1.4.1 Global Life Sciences Transactions Service Market Size by Region (2021-2026)
- 1.4.2 Global Life Sciences Transactions Service Market Size by Region (2027-2032)
- 1.5 Key Regions Life Sciences Transactions Service Market Size (2021-2032)
- 1.5.1 North America Life Sciences Transactions Service Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Life Sciences Transactions Service Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Life Sciences Transactions Service Market Size Growth Rate (2021-2032)
- 1.5.4 South America Life Sciences Transactions Service Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Life Sciences Transactions Service Market Size Growth Rate (2021-2032)
2 Life Sciences Transactions Service Market by Type
- 2.1 Type Introduction
- 2.1.1 Intellectual Property Licensing Transactions
- 2.1.2 Product Asset Transactions
- 2.1.3 Equity Mergers and Acquisitions
- 2.1.4 Other
- 2.2 Global Life Sciences Transactions Service Market Size by Type
- 2.2.1 Global Life Sciences Transactions Service Market Size Overview by Type (2021-2032)
- 2.2.2 Global Life Sciences Transactions Service Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Life Sciences Transactions Service Market Size Forecasted by Type (2027-2032)
- 2.3 Global Life Sciences Transactions Service Market Size by Regions
- 2.3.1 North America Life Sciences Transactions Service Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Life Sciences Transactions Service Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Life Sciences Transactions Service Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Life Sciences Transactions Service Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Life Sciences Transactions Service Market Size Breakdown by Type (2021-2026)
3 Life Sciences Transactions Service Market by Application
- 3.1 Type Introduction
- 3.1.1 Biopharmaceuticals and Innovative Therapies
- 3.1.2 Medical Devices and Diagnostics
- 3.1.3 Contract Research, Development, and Manufacturing Organizations
- 3.1.4 Digital Health and Healthcare Services
- 3.1.5 Others
- 3.2 Global Life Sciences Transactions Service Market Size by Application
- 3.2.1 Global Life Sciences Transactions Service Market Size Overview by Application (2021-2032)
- 3.2.2 Global Life Sciences Transactions Service Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Life Sciences Transactions Service Market Size Forecasted by Application (2027-2032)
- 3.3 Global Life Sciences Transactions Service Market Size by Regions
- 3.3.1 North America Life Sciences Transactions Service Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Life Sciences Transactions Service Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Life Sciences Transactions Service Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Life Sciences Transactions Service Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Life Sciences Transactions Service Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Life Sciences Transactions Service Industry Trends
- 4.2 Life Sciences Transactions Service Industry Drivers
- 4.3 Life Sciences Transactions Service Industry Opportunities and Challenges
- 4.4 Life Sciences Transactions Service Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Life Sciences Transactions Service Revenue (2021-2026)
- 5.2 Global Life Sciences Transactions Service Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Life Sciences Transactions Service Key Company Headquarters & Area Served
- 5.4 Global Life Sciences Transactions Service Company, Product Type & Application
- 5.5 Global Life Sciences Transactions Service Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Life Sciences Transactions Service Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Life Sciences Transactions Service Players Market Share by Revenue in 2025
- 5.6.3 2025 Life Sciences Transactions Service Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 A&L Goodbody
- 6.1.1 A&L Goodbody Company Information
- 6.1.2 A&L Goodbody Business Overview
- 6.1.3 A&L Goodbody Life Sciences Transactions Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 A&L Goodbody Life Sciences Transactions Service Product Portfolio
- 6.1.5 A&L Goodbody Recent Developments
- 6.2 Arnold & Porter
- 6.2.1 Arnold & Porter Company Information
- 6.2.2 Arnold & Porter Business Overview
- 6.2.3 Arnold & Porter Life Sciences Transactions Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Arnold & Porter Life Sciences Transactions Service Product Portfolio
- 6.2.5 Arnold & Porter Recent Developments
- 6.3 Baker McKenzie
- 6.3.1 Baker McKenzie Company Information
- 6.3.2 Baker McKenzie Business Overview
- 6.3.3 Baker McKenzie Life Sciences Transactions Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Baker McKenzie Life Sciences Transactions Service Product Portfolio
- 6.3.5 Baker McKenzie Recent Developments
- 6.4 Covington
- 6.4.1 Covington Company Information
- 6.4.2 Covington Business Overview
- 6.4.3 Covington Life Sciences Transactions Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Covington Life Sciences Transactions Service Product Portfolio
- 6.4.5 Covington Recent Developments
- 6.5 DLA Piper
- 6.5.1 DLA Piper Company Information
- 6.5.2 DLA Piper Business Overview
- 6.5.3 DLA Piper Life Sciences Transactions Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 DLA Piper Life Sciences Transactions Service Product Portfolio
- 6.5.5 DLA Piper Recent Developments
- 6.6 HaysMac
- 6.6.1 HaysMac Company Information
- 6.6.2 HaysMac Business Overview
- 6.6.3 HaysMac Life Sciences Transactions Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 HaysMac Life Sciences Transactions Service Product Portfolio
- 6.6.5 HaysMac Recent Developments
- 6.7 Holland & Knight
- 6.7.1 Holland & Knight Company Information
- 6.7.2 Holland & Knight Business Overview
- 6.7.3 Holland & Knight Life Sciences Transactions Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Holland & Knight Life Sciences Transactions Service Product Portfolio
- 6.7.5 Holland & Knight Recent Developments
- 6.8 Kirkland & Ellis LLP
- 6.8.1 Kirkland & Ellis LLP Company Information
- 6.8.2 Kirkland & Ellis LLP Business Overview
- 6.8.3 Kirkland & Ellis LLP Life Sciences Transactions Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Kirkland & Ellis LLP Life Sciences Transactions Service Product Portfolio
- 6.8.5 Kirkland & Ellis LLP Recent Developments
- 6.9 L.E.K. Consulting
- 6.9.1 L.E.K. Consulting Company Information
- 6.9.2 L.E.K. Consulting Business Overview
- 6.9.3 L.E.K. Consulting Life Sciences Transactions Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 L.E.K. Consulting Life Sciences Transactions Service Product Portfolio
- 6.9.5 L.E.K. Consulting Recent Developments
- 6.10 Morgan Lewis
- 6.10.1 Morgan Lewis Company Information
- 6.10.2 Morgan Lewis Business Overview
- 6.10.3 Morgan Lewis Life Sciences Transactions Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Morgan Lewis Life Sciences Transactions Service Product Portfolio
- 6.10.5 Morgan Lewis Recent Developments
- 6.11 Osborne Clarke
- 6.11.1 Osborne Clarke Company Information
- 6.11.2 Osborne Clarke Business Overview
- 6.11.3 Osborne Clarke Life Sciences Transactions Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Osborne Clarke Life Sciences Transactions Service Product Portfolio
- 6.11.5 Osborne Clarke Recent Developments
- 6.12 Pharma Bio Source
- 6.12.1 Pharma Bio Source Company Information
- 6.12.2 Pharma Bio Source Business Overview
- 6.12.3 Pharma Bio Source Life Sciences Transactions Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Pharma Bio Source Life Sciences Transactions Service Product Portfolio
- 6.12.5 Pharma Bio Source Recent Developments
- 6.13 Pinnacle
- 6.13.1 Pinnacle Company Information
- 6.13.2 Pinnacle Business Overview
- 6.13.3 Pinnacle Life Sciences Transactions Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Pinnacle Life Sciences Transactions Service Product Portfolio
- 6.13.5 Pinnacle Recent Developments
- 6.14 Reed Smith LLP
- 6.14.1 Reed Smith LLP Company Information
- 6.14.2 Reed Smith LLP Business Overview
- 6.14.3 Reed Smith LLP Life Sciences Transactions Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Reed Smith LLP Life Sciences Transactions Service Product Portfolio
- 6.14.5 Reed Smith LLP Recent Developments
- 6.15 RNA Advisors
- 6.15.1 RNA Advisors Company Information
- 6.15.2 RNA Advisors Business Overview
- 6.15.3 RNA Advisors Life Sciences Transactions Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 RNA Advisors Life Sciences Transactions Service Product Portfolio
- 6.15.5 RNA Advisors Recent Developments
- 6.16 Sidley Austin
- 6.16.1 Sidley Austin Company Information
- 6.16.2 Sidley Austin Business Overview
- 6.16.3 Sidley Austin Life Sciences Transactions Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 Sidley Austin Life Sciences Transactions Service Product Portfolio
- 6.16.5 Sidley Austin Recent Developments
- 6.17 Tenthpin
- 6.17.1 Tenthpin Company Information
- 6.17.2 Tenthpin Business Overview
- 6.17.3 Tenthpin Life Sciences Transactions Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.17.4 Tenthpin Life Sciences Transactions Service Product Portfolio
- 6.17.5 Tenthpin Recent Developments
- 6.18 Troutman Pepper Locke
- 6.18.1 Troutman Pepper Locke Company Information
- 6.18.2 Troutman Pepper Locke Business Overview
- 6.18.3 Troutman Pepper Locke Life Sciences Transactions Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.18.4 Troutman Pepper Locke Life Sciences Transactions Service Product Portfolio
- 6.18.5 Troutman Pepper Locke Recent Developments
- 6.19 WilmerHale
- 6.19.1 WilmerHale Company Information
- 6.19.2 WilmerHale Business Overview
- 6.19.3 WilmerHale Life Sciences Transactions Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.19.4 WilmerHale Life Sciences Transactions Service Product Portfolio
- 6.19.5 WilmerHale Recent Developments
7 North America
- 7.1 North America Life Sciences Transactions Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Life Sciences Transactions Service Market Size by Country (2021-2026)
- 7.3 North America Life Sciences Transactions Service Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Life Sciences Transactions Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Life Sciences Transactions Service Market Size by Country (2021-2026)
- 8.3 Europe Life Sciences Transactions Service Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Life Sciences Transactions Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Life Sciences Transactions Service Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Life Sciences Transactions Service Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Life Sciences Transactions Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Life Sciences Transactions Service Market Size by Country (2021-2026)
- 10.3 South America Life Sciences Transactions Service Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Life Sciences Transactions Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Life Sciences Transactions Service Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Life Sciences Transactions Service Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst